Chad vs Peru: Previously treated cases tested for RR-/MDR-TB
Chad
95.0%
in 2024
Peru
95.0%
in 2024
Chad rank
66th
Peru rank
66th
Previously treated cases tested for RR-/MDR-TB over time
- Chad
- Peru
How they compare
Chad currently reports 95.0% against 95.0% in Peru, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2011 it was Peru ahead.
Chad ranks 66th and Peru ranks 66th of 180 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Peru in 1.
Head to head by decade
| Decade | Chad | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 24.2% | 67.6% | 43.4% | Peru |
| 2020s | 96.2% | 82.4% | 13.8% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Chad or Peru?
- Chad, at 95.0% against 95.0% in Peru as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Chad and Peru?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Peru?
- 13 years are reported by both, from 2011 to 2024.
- How do Chad and Peru rank globally for previously treated cases tested for rr-/mdr-tb?
- Chad ranks 66th and Peru ranks 66th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.